| 2023-03-28 | +0.68 % |
|
| 2023-03-27 | -0.1 % |
|
| 2023-03-24 | +0.99 % |
|
| 2023-03-23 | +1.26 % |
|
| 2023-03-22 | -2.29 % |
|
| 2023-03-20 | -0.84 % |
|
| 2023-03-15 | -0.49 % |
- During GE's Investor Conference, GE Healthcare reaffirmed its 2023 guidance, which includes high-single-digit organic revenue growth, adjusted EPS of $1.60 to $2.00, and free cash flow of $3.4 billion to $4.2 billion; however, GEHC stock was down 0.49% last night likely due to broader market concerns and not specific to the company's performance.
- GE Healthcare (GEHC) stock went down by 0.49% as a result of Larry Culp's efforts to clean up the mess Welch left after playing earnings and accounting games, leading to a reversal of Welch's heritage as the company is now being dismantled.
- GE Healthcare (GEHC) stock went down because the company's profitability was impacted by higher costs despite its revenue increasing by 4.3% year-over-year and acquisitions such as Imactis and Caption Health.
- GE Healthcare (GEHC) stock was down -0.49% last night, possibly due to a research article linking trichloroethylene, a widely-used industrial solvent and common environmental contaminant, to Parkinson's disease, which calls for further research, protection, and remediation of its contamination.
|
| 2023-03-13 | +1.69 % |
|